Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006.
作者： David C Bean , Daniel Krahe , David W Wareham
关键词:
摘要: Escherichia coli is the commonest cause of community and … We therefore set out to determine levels of resistance to 8 … trimethoprim and cefpodoxime was determined for 11,865 E. …
biomedcentral.com
springer.com
core.ac.uk
paperity.org参考文章(15)
J.-I. Alós, M.-G. Serrano, J.-L. Gómez-Garcés, J. Perianes, Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data Clinical Microbiology and Infection. ,vol. 11, pp. 199- 203 ,(2005) , 10.1111/J.1469-0691.2004.01057.X
D. Felmingham, D.J. Farrell, I. Morrissey, D. De Rubeis, M. Robbins, A UK Multicentre Study of the Antimicrobial Susceptibility of Bacterial Pathogens Causing Urinary Tract Infection Journal of Infection. ,vol. 46, pp. 94- 100 ,(2003) , 10.1053/JINF.2002.1091
A. Baerheim, Empirical treatment of uncomplicated cystitis: Keep it simple BMJ. ,vol. 323, pp. 1197- 1198 ,(2001) , 10.1136/BMJ.323.7323.1197
Benjamin A. Lipsky, Urinary Tract Infections in Men Annals of Internal Medicine. ,vol. 110, pp. 138- 150 ,(1989) , 10.7326/0003-4819-110-2-138
Tetsuro Matsumoto, Tetsuro Muratani, Newer carbapenems for urinary tract infections International Journal of Antimicrobial Agents. ,vol. 24, pp. 35- 38 ,(2004) , 10.1016/J.IJANTIMICAG.2004.03.001
Kalpana Gupta, Thomas M. Hooton, Walter E. Stamm, Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Annals of Internal Medicine. ,vol. 135, pp. 41- 50 ,(2001) , 10.7326/0003-4819-135-1-200107030-00012
Leesa Hames, Craig E. Rice, Antimicrobial resistance of urinary tract isolates in acute uncomplicated cystitis among college-aged women: choosing a first-line therapy. Journal of American College Health. ,vol. 56, pp. 153- 156 ,(2007) , 10.3200/JACH.56.2.153-158
E. Karisik, M. J. Ellington, D. M. Livermore, N. Woodford, Virulence factors in Escherichia coli with CTX-M-15 and other extended-spectrum β-lactamases in the UK Journal of Antimicrobial Chemotherapy. ,vol. 61, pp. 54- 58 ,(2007) , 10.1093/JAC/DKM401
Husnu Pullukcu, Meltem Tasbakan, Oguz Resat Sipahi, Tansu Yamazhan, Sohret Aydemir, Sercan Ulusoy, Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections International Journal of Antimicrobial Agents. ,vol. 29, pp. 62- 65 ,(2007) , 10.1016/J.IJANTIMICAG.2006.08.039
D. M. Livermore, R. Canton, M. Gniadkowski, P. Nordmann, G. M. Rossolini, G. Arlet, J. Ayala, T. M. Coque, I. Kern-Zdanowicz, F. Luzzaro, L. Poirel, N. Woodford, CTX-M: changing the face of ESBLs in Europe Journal of Antimicrobial Chemotherapy. ,vol. 59, pp. 165- 174 ,(2006) , 10.1093/JAC/DKL483